The global syringes market is poised for significant expansion, forecasted to grow from USD 26.8 billion in 2025 to USD 63.4 billion by 2035, marking an impressive CAGR of 9.0%. This growth builds upon a robust foundation, as sales in 2024 reached USD 24.5 billion, driven by increasing healthcare demands, innovations in drug delivery, and global efforts to strengthen immunization programs.
A syringe is a medical device used to inject or withdraw fluids from the body. Though simple in design, it is versatile in function, playing a pivotal role in vaccine administration, anesthesia delivery, insulin management, and more. Syringes are broadly classified into two types: disposable and reusable. Further segmentation includes safety syringes, insulin syringes, tuberculin syringes, and prefilled syringes, each tailored to specific medical needs.
Discover Market Opportunities – Get Your Sample of Our Industry Overview Today!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14292
One of the strongest drivers of the syringes market is the rising demand for precise and safe drug delivery systems. Syringes offer controlled dosage administration, a critical requirement for chronic disease treatments, insulin delivery, and vaccination programs.
As biologics and specialty pharmaceuticals grow in market share, the need for syringes compatible with high-viscosity drugs is also expanding. This creates a parallel demand for advanced materials and low dead-space designs, helping improve efficiency and minimize medication waste.
Growth Is Real. So Is the Risk.
Rising diabetes. An aging global population. A surge in biologic therapies. The move toward at-home care. Together, they’re pushing demand for injections through the roof. And with each injection comes one common denominator: the syringe.
According to FMI, disposable syringes dominate the landscape. For good reason—they reduce infection risk, prevent cross-contamination, and are widely adaptable. But here’s the catch: most health systems treat them like afterthoughts. Commodity goods. Cheap plastic. Nothing to worry about.
Global Growth, Uneven Readiness
FMI’s data reveals a market stretched across two extremes. On one hand, North America accounts for 42.5% of global syringe demand, driven by large-scale hospital systems, chronic illness, and pharmaceutical dependency. On the other hand, Asia Pacific is growing faster, fueled by infrastructure buildouts and public health programs.
This isn’t just a tug-of-war between two regions. It’s a global supply chain under stress—where production surges in one part of the world can leave another vulnerable. FMI flags this imbalance as a major concern moving forward. And they’re right.
Disposable, Yes. But Not Optional.
One of the greatest misconceptions in healthcare today is that syringes are replaceable, interchangeable, and secondary. FMI’s data proves otherwise.
Without syringes, vaccinations don’t happen. Chemotherapy halts. Insulin is useless. Injections for autoimmune diseases, hormone therapies, local anesthetics all suspended.
Think about that. Billions of critical procedures paralyzed by the absence of a two-dollar device.
Even worse, FMI highlights safety issues in certain parts of the market. Poorly regulated manufacturers. Reused needles. Inferior plastics. These aren’t minor quality complaints; they’re threats to life.
In 2024 alone, millions of injections will take place under compromised conditions. That’s not acceptable, and it’s not just a developing-world problem. It’s systemic.
Prefilled Syringes: The Future—If We’re Ready
There’s a bright spot. According to FMI, prefilled syringes are poised to change the game. More accurate. More sterile. More efficient.
They’re ideal for vaccines and biologics. They reduce medical waste and save time in critical care. But they also require new infrastructure, better handling protocols, and significantly higher upfront costs.
Will governments invest? Will hospitals upgrade? Will regulators adapt fast enough?
That’s still up for debate. But FMI’s projection is clear: prefilled syringes are gaining ground, and those who adopt them early will lead the next phase of healthcare delivery.
Key Players of the Syringes Market
- Schott AG – Specializing in high-quality glass syringes for biologics and injectable drugs, with an emphasis on precision engineering and contamination prevention.
- West Pharmaceutical Services, Inc. – Developing smart drug delivery systems for pre-filled syringes, enhancing medication safety and tracking capabilities.
- B. Braun Melsungen AG – Expanding its portfolio of safety-engineered syringes for infection control, ensuring global compliance with needlestick prevention regulations.
- Retractable Technologies, Inc. – Pioneering retractable needle syringes to reduce needlestick injuries, promoting safer medical waste disposal and eco-conscious syringe solutions.
- Weigao Group – Growing its market presence with cost-effective disposable syringes for emerging economies, supporting government-driven healthcare initiatives.
Key Segments: Syringes Market
By Material:
- Glass Syringes
- Plastic Syringes
- Stainless Steel Syringes
By Syringe Type:
- Disposable Syringes
- Reusable Syringes
By Capacity:
- Small Volume Syringes (1 to 10 ml)
- Medium Volume Syringes (11 to 20 ml)
- Large Volume Syringes (Above 20ml)
By End-Use Application:
- Hospitals & Clinics
- Diagnostic Centers
- Vaccination Programs
- Veterinary Use
- Home Healthcare
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Eastern Europe
- Western Europe
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
